Blood Donor Eligibility

You May Be Eligible to Donate If You:

  • Are in general good health.

  • Are 16 years of age or older. Individuals under the age of 18 must provide a signed parental/guardian permission form.

  • Weigh at least 120 pounds.
  • Have not made a whole blood, double red cell, platelet or plasma donation prior to becoming eligible.
  • Have normal blood pressure, pulse, temperature and hemoglobin screenings.
  • Are not pregnant.
  • Do not have a cold.
  • Are not under a doctor’s care for any serious illness or injury.
  • Speak English.

To learn more about your blood type and blood, check out our fun facts!

Appointments are required: Schedule your appointment ahead of time to help our team members safely see as many donors as possible.

We’re counting on your generous gift of life. If you can’t make your donation time, please reschedule here or by calling us at 800.287.4903.


FDA/CBER is responsible for regulatory oversight of the U.S. blood supply. FDA promulgates and enforces standards for blood collection and for the manufacturing of blood products, including both transfusible components of whole blood, pharmaceuticals derived from blood cells or plasma, and related medical devices. 

  • May 2022 - Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease (cVJD)
    • The FDA has removed the deferral recommendation for individuals associated with geographic risk of vCJD, commonly referred to as Mad Cow Disease, for time spent in the United Kingdom (U.K.) from 1980-1996; time spent in France and Ireland from 1980-2001; and receipt of a blood transfusion in the U.K., France, or Ireland from 1980-present.
    • Find additional resources here
  • On Thursday, May 11, the U.S. Food and Drug Administration (FDA) finalized recommendations for assessing blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

    • Blood centers across the United States now have approximately 6 to 12 months to implement the new, mandated rules. This involves modifying many internal systems, processes and software as well as training for blood center team members. LifeServe Blood Center expects to implement the FDA final guidance before the end of 2023 and will update communications regarding the timeline for implementation as information becomes available. 

Do you have a question about your eligibility? We’ve got your answer. Call us at 800.287.4903 or e-mail